264 related articles for article (PubMed ID: 11246539)
1. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
[TBL] [Abstract][Full Text] [Related]
2. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
[TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
4. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study.
Smith FB; Lee AJ; Hau CM; Rumley A; Lowe GD; Fowkes FG
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):43-50. PubMed ID: 10691098
[TBL] [Abstract][Full Text] [Related]
5. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
6. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
7. Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):171-6. PubMed ID: 15649725
[TBL] [Abstract][Full Text] [Related]
8. Increased hemostatic molecular markers in patients undergoing anticoagulant therapy.
Wada H; Ikuma H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Onoda K; Yamada N; Ohta T; Nishioka J; Sakuragawa N; Shiku H
Semin Thromb Hemost; 2000; 26(1):113-8. PubMed ID: 10805292
[TBL] [Abstract][Full Text] [Related]
9. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease.
Unlü Y; Karapolat S; Karaca Y; Kiziltunç A
Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke.
Soncini M; Gasparini P; Lorena M; Motta A; Cimminiello C
Minerva Cardioangiol; 2000 Nov; 48(11):349-56. PubMed ID: 11214426
[TBL] [Abstract][Full Text] [Related]
11. Fibrin D-dimer, haemostatic factors and peripheral arterial disease.
Lee AJ; Fowkes FG; Lowe GD; Rumley A
Thromb Haemost; 1995 Sep; 74(3):828-32. PubMed ID: 8571305
[TBL] [Abstract][Full Text] [Related]
12. Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.
Monaco C; Rossi E; Milazzo D; Citterio F; Ginnetti F; D'Onofrio G; Cianflone D; Crea F; Biasucci LM; Maseri A
J Am Coll Cardiol; 2005 Jan; 45(2):238-43. PubMed ID: 15653021
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis.
Kienast J; Thompson SG; Raskino C; Pelzer H; Fechtrup C; Ostermann H; van de Loo J
Thromb Haemost; 1993 Oct; 70(4):550-3. PubMed ID: 8115978
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of hemostasis activation markers in acute deep vein thrombosis].
Tajanko E; Galar M; Piszcz J; Kłoczko J
Pol Arch Med Wewn; 2002 Mar; 107(3):237-41. PubMed ID: 12107982
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of hemostatic coagulation markers in prethrombosis state of pregnancy induced hypertension].
Shi Q; Chen C; Wang XF; Wang HL
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):733-6. PubMed ID: 15634496
[TBL] [Abstract][Full Text] [Related]
16. D-dimers predict stroke subtype when assessed early.
Isenegger J; Meier N; Lämmle B; Alberio L; Fischer U; Nedeltchev K; Gralla J; Kohler HP; Mattle HP; Arnold M
Cerebrovasc Dis; 2010; 29(1):82-6. PubMed ID: 19907168
[TBL] [Abstract][Full Text] [Related]
17. TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterization.
Biancardi M; Cimminiello C; Toschi V; Schiavina G; Regalia F; Casolo F; Bonfardeci G
Semin Thromb Hemost; 1996; 22 Suppl 1():61-5. PubMed ID: 8807731
[TBL] [Abstract][Full Text] [Related]
18. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
19. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
20. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]